MY187125A - Hydrogel formulation for wound healing and/or treatment - Google Patents

Hydrogel formulation for wound healing and/or treatment

Info

Publication number
MY187125A
MY187125A MYPI2014003164A MYPI2014003164A MY187125A MY 187125 A MY187125 A MY 187125A MY PI2014003164 A MYPI2014003164 A MY PI2014003164A MY PI2014003164 A MYPI2014003164 A MY PI2014003164A MY 187125 A MY187125 A MY 187125A
Authority
MY
Malaysia
Prior art keywords
mixture
hydrogel formulation
hydrogel
polymer
wound
Prior art date
Application number
MYPI2014003164A
Inventor
Mohd Yunus Rosli
Gupta Arun
Kumaran Priyaah
Original Assignee
Univ Malaysia Pahang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaysia Pahang filed Critical Univ Malaysia Pahang
Priority to MYPI2014003164A priority Critical patent/MY187125A/en
Publication of MY187125A publication Critical patent/MY187125A/en

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

The present invention described a method for preparing a hydrogel formulation, said method comprising the following steps: (a) forming a mixture of 20-40% (w/w%) chicken feather keratin in polymer solution; (b) pouring the resulting mixture into a dish to a desired thickness; and (c) subjecting the mixture to repeated freezing and thawing cycle until a hydrogel is formed, wherein the polymer solution comprises a mixture of synthetic polymer and a bio-polymer, and wherein each freezing is carried out at -83C for 1 hour followed by thawing at room temperature for 1 hour. The hydrogel formulation, when used as a wound dressing, renders high absorption, contours to a wound site and maintains the wound in a moist state to promote healing thereof.
MYPI2014003164A 2014-11-13 2014-11-13 Hydrogel formulation for wound healing and/or treatment MY187125A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2014003164A MY187125A (en) 2014-11-13 2014-11-13 Hydrogel formulation for wound healing and/or treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2014003164A MY187125A (en) 2014-11-13 2014-11-13 Hydrogel formulation for wound healing and/or treatment

Publications (1)

Publication Number Publication Date
MY187125A true MY187125A (en) 2021-09-02

Family

ID=81329890

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014003164A MY187125A (en) 2014-11-13 2014-11-13 Hydrogel formulation for wound healing and/or treatment

Country Status (1)

Country Link
MY (1) MY187125A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114796620A (en) * 2022-04-24 2022-07-29 广东顺德工业设计研究院(广东顺德创新设计研究院) Interpenetrating network hydrogel used as medical implant material and preparation method and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114796620A (en) * 2022-04-24 2022-07-29 广东顺德工业设计研究院(广东顺德创新设计研究院) Interpenetrating network hydrogel used as medical implant material and preparation method and application thereof
CN114796620B (en) * 2022-04-24 2023-09-29 广东顺德工业设计研究院(广东顺德创新设计研究院) An interpenetrating network hydrogel used as a medical implant material and its preparation method and application

Similar Documents

Publication Publication Date Title
BR112016011065A8 (en) crystalline compound, pharmaceutical composition, dosage form, method for treating anemia
NI201700128A (en) OBETICOLIC ACID COMPOSITIONS AND METHODS OF USE.
EP4338803A3 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
MX390111B (en) STABILIZED HYPOHALOSE ACID SOLUTIONS.
HRP20200431T1 (en) Polymer based hydrogel
GB2535117A (en) A ready to use biodegradable and biocompatable device and a method of preparation thereof
EP3928800A3 (en) Dry powder composition comprising long-chain rna
WO2017163132A3 (en) Use of umbilical cord blood derived exosomes for tissue repair
BR112016021130A2 (en) THERAPEUTIC NANOPARTICLES, PHARMACEUTICAL COMPOSITION INCLUDING THE SAID NANOPARTICLES, PROCESS FOR THE PREPARATION AND USE THEREOF
HK1232147A1 (en) Cenicriviroc for the treatment of fibrosis
WO2019040106A3 (en) Compounds, salts thereof and their use in the treatment of diseases
MX2016009852A (en) Post-procedure skin care systems, compositions, and methods of use thereof.
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
EP3312151A4 (en) Oxidation-induced self-healing ceramic composition containing healing activator, method for producing same, use of same, and method for enhancing functionality of oxidation-induced self-healing ceramic composition
HK1244806A1 (en) Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
BR112016009178A8 (en) method of preparing a tissue product, and, using a tissue product
WO2016046156A8 (en) Substituted oxopyridine derivatives
MX373524B (en) STABILIZED HYPOCHLOROUS ACID SOLUTION AND ITS USE.
WO2015026992A3 (en) Hair treatment methods and kits thereof
WO2015189712A3 (en) Silicone-based biophotonic compositions and uses thereof
WO2015075062A3 (en) Method of treating hair
TN2018000188A1 (en) Isoindole compounds
CA2971807C (en) Process for making a viscous composition comprising whey protein
BR112018008769A2 (en) pharmaceutical formulations, reconstituted and lyophilized aqueous liquid formulations, syringe, method of manufacturing a pharmaceutical formulation, method for treating a disease and use of a reconstructed formulation
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease